The role of sulphasalazine in African patients with HIV-associated seronegative arthritis.
A O
AO
Adebajo
M
M
Mijiyawa
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D016918:Arthritis, Reactive / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D013166:Spondylitis / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D012460:Sulfasalazine / Q000627:therapeutic use*; D014037:Togo; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D012460:Sulfasalazine